The life sciences industry is young, extremely dynamic and unlike any other in embracing so many different fields and disciplines. Besides the classical biosciences such as biochemistry, biotechnology, immunology or microbiology, many new fields have arisen from the merging of different scientific disciplines – such as bioinformatics, biomedical engineering, or medical biological chemistry. There is very strong demand for research and enormous innovative potential in all of these fields. Germany is not only an important sales market for life sciences companies, but also a centre of innovation for numerous start-ups.

Following rapid growth in recent years, there are now signs of market consolidation – and IP, especially, will gain importance as a corporate asset in that context. However, new, revolutionary technologies, such as CRISPR in the genome editing field, always involve new challenges, too.

The Life Sciences group at Eisenführ Speiser represents not only large and medium-size companies but also start-ups, especially in the fields of biotechnology, plant biotechnology, microbiology, biomedicine, functional food, bioinformatics, digital health, food chemistry, scents and aromatics, and pharmaceutics.